Literature DB >> 6315125

Renal graft dysfunction during infection with cytomegalovirus: association with IgM lymphocytotoxins and HLA-DR3 and DR7.

W M Baldwin, F H Claas, A van Es, W L Westedt, G van Gemert, M R Daha, L A van Es.   

Abstract

Of 121 consecutive adult recipients of cadaver renal transplants who were treated with low dose steroids and azathioprine, 23 developed active cytomegalovirus infections. These 23 patients were divided into three groups on the basis of their symptoms related to the infection: five patients had no renal, respiratory, or haematological abnormalities; seven had renal dysfunction; and nine had renal dysfunction plus respiratory or haematological abnormalities. Two patients were regarded as a separate group because their infections occurred two to four weeks after graft nephrectomy. All but three of the patients produced IgM or IgG lymphocytotoxins during their infections. In the patients with mild infections and in control patients without infections, however, these lymphocytotoxins were predominantly IgG antibodies that were not precipitated by 3.5% macrogol (polyethylene glycol). In contrast, 12 of the 16 patients with renal dysfunction during their infections had broadly reactive IgM lymphocytotoxins. These IgM lymphocytotoxins lysed T as well as B lymphocytes at 22 degrees C and were precipitated by 3.5% macrogol, suggesting that they were circulating as immune complexes. Rheumatoid factors were found in sera from nine patients with cytomegalovirus infections, seven of whom developed leukopenia or pneumonia, or both, in addition to renal dysfunction. Some of these immune responses associated with cytomegalovirus infection in transplant recipients may be genetically controlled since 10 of 11 patients positive for HLA-DR3 or DR7 produced IgM lymphocytotoxins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315125      PMCID: PMC1549484          DOI: 10.1136/bmj.287.6402.1332

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  23 in total

1.  Clinical manifestations of renal allograft derived primary cytomegalovirus infection.

Authors:  R F Betts; R B Freeman; R G Douglas; T E Talley
Journal:  Am J Dis Child       Date:  1977-07

Review 2.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

3.  Immunologic abnormalities induced by postperfusion cytomegalovirus infection.

Authors:  G L Kantor; L S Goldberg; B L Johnson; M M Derechin; E V Barnett
Journal:  Ann Intern Med       Date:  1970-10       Impact factor: 25.391

4.  Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus.

Authors:  J M Ahearn; T T Provost; C A Dorsch; M B Stevens; W B Bias; F C Arnett
Journal:  Arthritis Rheum       Date:  1982-09

5.  Less aggressive rejection therapy and low-dose corticosteroids leading to satisfactory cadaveric kidney graft survival and low morbidity rate.

Authors:  J P van Hooff; A van Es; M I Koolen; M W Kalff; P H van den Broek; J de Graeff
Journal:  Proc Eur Dial Transplant Assoc       Date:  1980

6.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.

Authors:  M Fiala; J E Payne; T V Berne; T C Moore; W Henle; J Z Montgomerie; S N Chatterjee; L B Guze
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

7.  Cytomegalovirus infection in patients with renal transplants: potentiation by antithymocyte globulin and an incompatible graft.

Authors:  R F Pass; R J Whitley; A G Diethelm; J D Whelchel; D W Reynolds; C A Alford
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

8.  Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.

Authors:  W M Baldwin; A van Es; R M Valentijn; G W van Gemert; M R Daha; L A Vanes
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

9.  Glomerulopathy associated with cytomegalovirus viremia in renal allografts.

Authors:  W P Richardson; R B Colvin; S H Cheeseman; N E Tolkoff-Rubin; J T Herrin; A B Cosimi; A B Collins; M S Hirsch; R T McCluskey; P S Russell; R H Rubin
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245

10.  Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy.

Authors:  R M Valentijn; R H Kauffmann; G B de la Rivière; M R Daha; L A Van ES
Journal:  Am J Med       Date:  1983-03       Impact factor: 4.965

View more
  2 in total

1.  HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation.

Authors:  H W Roenhorst; A M Tegzess; J M Beelen; J M Middeldorp; T H The
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-07

2.  Whole genome sequencing reveals extended natural transformation in Campylobacter impacting diagnostics and the pathogens adaptive potential.

Authors:  Julia C Golz; Lennard Epping; Marie-Theres Knüver; Maria Borowiak; Felix Hartkopf; Carlus Deneke; Burkhard Malorny; Torsten Semmler; Kerstin Stingl
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.